The plant-based food market sees a demand surge as consumers seek out new and novel products. Producers are partnering with firms like CRB to design and build research and production facilities that will adapt and grow as the segment’s products evolve.
CRB is proud to announce that the Amicus Therapeutics Research and Gene Therapy Center facility has won Engineering News-Record (ENR) MidAtlantic’s 2020 Best Projects (Award of Merit) in the Healthcare category.
Tom Rychlewski leverages CRB’s expertise for companies considering entry into the plant-based protein segment in Food Engineering‘s “Plant-based protein market offers potential for product, processing innovation.”
Mark Paskanik, AIA, NCARB will lead a webinar on “Innovative Science with Less and the Lab Future” at the Lab Design Digital Summit. Taking place May 11-13, this digital summit will feature a series of informative webinars that will bring together lab management leaders with experts in the laboratory and healthcare design community.
As the food and beverage market shifts to a new way of working amid COVID-19, manufacturers remain hopeful for 2020. Jason Robertson joins Food Processing to recap industry figures for 2019 and share forward-facing food and forward-facing challenges in “2020 Capital Spending Outlook: Getting to Yes on Capital Projects.”
Vaccines and therapies can’t come soon enough for a world desperate to limit or erase the threat of COVID-19. But there’s good news from an industry long accustomed to a speed-to-market mentality: Pharmaceutical companies are fully engaged.
CRB is a proud sponsor of the 2020 ISPE Aseptic Conference which will focus on providing flexible and reliable solutions for the implementation and management of the latest in aseptic, barrier, containment, and aseptic best practice technologies, including automated visual inspections.
Allan Bream, Bioprocess Specialist at CRB, was recently featured in Pharma’s Almanac, with an article entitled, “Isolator Design in Cell Therapy Facilities.”
Cell and gene therapy manufacturing must be performed under aseptic conditions and with good aseptic handling practices to ensure patient safety. The use of isolators can help address this critical need, but designing isolators for advanced therapy medicinal product (ATMP) processes can be challenging.
Noel Maestre, PE and Emily Thompson, PE will be conducting a webinar via Cell and Gene Therapy Insights on how to deliver multi-product or multimodal Advanced Therapy Medicinal Product (ATMP) facilities to adapt to an evolving product pipeline.
Supporting our recent project growth in southern California, CRB is pleased to announce we’ve opened a new office in Tustin, Calif. The location will allow us to attract the best talent in the southern California region, pursue new business in Orange County and assist new and ongoing projects affiliated with its office in El Segundo, Calif.